Not all fillers are the same. The product used for penile girth enhancement affects everything from how the result feels and lasts to the safety profile of the procedure itself. We use Teosyal, exclusively. Here is why.
Hyaluronic acid (HA) is a naturally occurring molecule found throughout the human body — in skin, connective tissue, joints, and the vitreous of the eye. It binds water aggressively (up to 1,000 times its own weight), gives tissue its turgor, and acts as a lubricant between tissue layers. Because HA is a native molecule, the body does not mount a meaningful immune response to it, and it is gradually metabolised back into its constituent parts over 12–24 months.
This biocompatibility is why HA dominates the global aesthetic filler market. It is used for lips, cheeks, under-eyes, hands, jawline, and — since the mid-2000s — increasingly for genital and body contouring. The global aesthetic industry has more than two decades of safety data on HA-based fillers across hundreds of millions of procedures.
Teosyal is a family of HA fillers manufactured by Teoxane Laboratories SA, based in Geneva, Switzerland. Teoxane is one of only a handful of filler manufacturers with full vertical control over its production chain — it synthesises, cross-links, and packages its own HA. Teosyal has been on the European market since 2003 and holds a CE mark (the European Union's medical device certification) as a Class III medical device, meaning it has been independently assessed for safety, clinical performance, and manufacturing quality.
For penile girth enhancement, the formulation used is from Teoxane's body-contouring range, selected for three properties: high cross-linking density, high cohesivity, and a rheological profile that holds shape under tissue pressure rather than flattening out.
Raw hyaluronic acid in the body is a free-floating polysaccharide — it has a half-life of about one day. To make it useful as a filler, the molecule is chemically bonded to itself (typically with BDDE, 1,4-butanediol diglycidyl ether) to form a three-dimensional gel network. The density of those cross-links determines how long the filler lasts, how firm it feels, and how well it holds shape. Higher density = longer lasting = firmer. Teosyal's body-contouring range sits at the premium end of cross-linking density, which is why it lasts 12–24 months where less-dense facial fillers last 6–9 months.
A significant number of clinics worldwide — and a particularly high proportion in the lowest-cost medical tourism markets — use unbranded or house-brand HA filler. These products are typically manufactured in Asia, repackaged under a marketing name, and sold at a fraction of the cost of a certified European or Korean brand. They are not uniformly bad, but they are uniformly opaque: the cross-linking chemistry is not disclosed, the clinical data is minimal or non-existent, and batch traceability is often absent.
For a procedure in which filler is deposited in a sensitive, functional, and highly vascular area, using a filler you cannot trace is a risk we are not prepared to take on behalf of our patients. Teosyal is expensive because it is manufactured to a traceable, auditable, published standard — and we consider that expense non-negotiable.
| Option | How it works | Duration | Reversible? | Risk profile |
|---|---|---|---|---|
| Teosyal HA filler (this clinic) | Cross-linked HA gel deposited in subcutaneous plane | 12–24 months | Yes — hyaluronidase dissolves within 24–48h | Low; mild bruising / asymmetry most common |
| Generic / unbranded HA filler | Same principle, uncertified product | Variable, often shorter | In theory, yes | Higher unknown-variables risk; batch traceability poor |
| PMMA (polymethylmethacrylate) | Permanent microsphere filler | Permanent (does not degrade) | No — not reversible | Granuloma, migration, permanent deformity if outcome is imperfect |
| Silicone (injectable) | Liquid silicone, illegal in most jurisdictions for this use | Permanent | No — requires surgical excision | High; migration, granuloma, severe disfigurement possible |
| Autologous fat grafting | Fat harvested by liposuction, purified, reinjected | Partial retention, 40–70% over 1 year | Partially — volume loss, not enzymatic reversal | Moderate; donor site morbidity, unpredictable retention, lumps |
| Dermal matrix grafting (surgical) | Surgical placement of acellular dermal matrix | Semi-permanent | Surgical revision only | Surgical risks, scarring, recovery measured in weeks |
| Penile implant (inflatable) | Surgical implant for erectile dysfunction, not girth | Permanent device | No — device revision only | Major surgery; not indicated for cosmetic girth alone |
The comparison table above is not an argument that HA filler is the "best" option for every patient, in every circumstance. It is an argument that HA filler is the only option that combines immediate, visible results with full reversibility, an outpatient procedure, and a safety profile supported by peer-reviewed literature. For most patients seeking non-surgical girth enhancement, that combination is what makes it the international standard.
Permanent fillers — PMMA, silicone, or any product marketed as "lifetime", "lasting forever", or "no need for top-ups" — are banned or heavily restricted in most developed-world regulatory jurisdictions for penile use. They persist in the literature only as case reports of complications: granulomas, migration, disfigurement, infection, and in some cases the need for extensive corrective surgery with poor cosmetic outcome.
If you are offered a filler that is described as "permanent" or "never needs replacing", decline it. An HA top-up every 12–24 months is a trivial inconvenience. The price of avoiding that inconvenience is the loss of the ability to reverse the treatment if your anatomy changes, your preference changes, or a complication occurs. That is a price no patient should accept.
Once fully settled, the filler integrates with the surrounding soft tissue in a way that is indistinguishable from native tissue to touch, for both the patient and their partner. During the first 1–2 weeks, some patients describe a mild firmness which then softens. The filler remains flexible — it does not stiffen the shaft or interfere with the mechanism of erection, and it does not affect sensitivity.
The product matters. The technique matters. The physician matters. Worldwide, the highest-quality clinical centres performing HA penile girth enhancement converge on the same small number of premium HA fillers, injected with blunt cannulas, by specialists who do this procedure every day. That is the standard we hold ourselves to — because anything less is a risk the patient, not the clinic, ends up absorbing. — Clinical rationale, Fill in Istanbul
Every patient receives the Teosyal batch number and expiry date on their procedure record. Request a detailed spec sheet during your free consultation.